Cloning and functional characterization of the HRASLS2 gene
- 28 December 2007
- journal article
- Published by Springer Nature in Amino Acids
- Vol. 35 (1), 129-137
- https://doi.org/10.1007/s00726-007-0612-2
Abstract
The HRAS-like suppressor 2 (HRASLS2) gene belongs to the H-REV107 gene family involved in the regulation of cell growth and differentiation. HRASLS2 is expressed at high levels in normal tissues of the small intestine, kidney, and trachea. We cloned HRASLS2 cDNA from human SW480 colon cancer cells. Most wild-type, and some N- and C-terminal truncated HRASLS2 (HRASLS2ΔNΔC) were expressed as a granular pattern located at perinuclear region in HtTA cervical cancer cells, while truncation at the C-terminus only (HRASLS2ΔC) resulted in a diffuse pattern. Wild-type HRASLS2 significantly suppressed colony formation of HeLa and HCT116 cells. HRASLS2ΔNΔC significantly inhibited colony formation of HCT116 cells, but HRASLS2ΔC did not affect cell growth. HRASLS2 suppressed the RAS-GTP levels and total RAS protein by 44% and 25%, respectively in HtTA cells; however, the suppression was not observed in truncated HRASLS2 variants. In conclusion, the HRASLS2 protein suppressed growth and RAS activities of cancer cells, and the C-terminal hydrophobic domain appeared to be indispensable for both activities.Keywords
This publication has 19 references indexed in Scilit:
- RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatusCellular Signalling, 2007
- Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cellsJournal of Cell Science, 2007
- RIG1 inhibits the Ras/mitogen-activated protein kinase pathway by suppressing the activation of RasCellular Signalling, 2006
- Evidence that sequence homologous region in LRAT-like proteins possesses anti-proliferative activity and DNA binding properties: translational implications and mechanism of actionCarcinogenesis: Integrative Cancer Research, 2005
- A novel transglutaminase activator forms a complex with type 1 transglutaminaseOncogene, 2004
- A Novel Tumor Suppressor Protein Promotes Keratinocyte Terminal Differentiation via Activation of Type I TransglutaminaseJournal of Biological Chemistry, 2003
- Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotypeOncogene, 2003
- The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNγ-induced cell death in human ovarian carcinoma cellsOncogene, 2002
- hH-Rev107, a class II tumor suppressor gene, is expressed by post-meiotic testicular germ cells and CIS cells but not by human testicular germ cell tumorsOncogene, 2001
- Growth-inhibitory Activity and Downregulation of the Class II Tumor-suppressor Gene H-rev107 in Tumor Cell Lines and Experimental TumorsThe Journal of cell biology, 1997